Adolescent Viral Load Suppression: Challenges and Success Stories
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
Linkage Navigation Program provides an immediate connection to same-day medical care and medical case management services, promoting timely linkage to care and services, and tailored individualized care operationalizing initiatives such as Test N Treat and Test N PrEP with positive health outcomes for Ryan White clients.
Resource (Conference Presentation) updated 09/14/2023
Successes and lessons learned will be shared from three metropolitan areas on incorporating STI testing and treatment for prevention clients within an HIV medical home setting, along with how offering STI treatment impacts early identification service outcomes (e.g., HIV positivity rates, linkage to care referrals, and the rapid start of HIV treatment).
Resource (Conference Presentation) updated 09/14/2023
The Alabama Quality Management Group (AQMG) is a consortium of quality leaders representing all Alabama RWHAP Part C and D clinics, over 80% of Alabama's HIV-diagnosed population. Data for Care Alabama (D4C-AL), a CDC-funded retention-in-care project, uses risk-stratification based on missed visits. It is currently being implemented at one site but will continue to be implemented over time.
Resource (Conference Presentation) updated 09/14/2023
This presentation discusses results from the HRSA Special Projects of National Significance Evidence-Informed Approaches to Improving Health Outcomes for people with HIV project. It highlights the value of evidence scoring in conjunction with impact assessments of real-world experts and implementers to increase potential adoption and implementation success of evidence-based and evidence-informed interventions.
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
Undetectable=Untransmittable: individuals who maintain viral suppression don't transmit HIV to their sexual partners. Yet some providers are uncomfortable discussing the implications of viral suppression in clinical encounters. This workshop will explore approaches to reduce provider discomfort in discussing U=U and present strategies to convey this message.
Resource (Conference Presentation) updated 09/14/2023
This presentation assesses social determinants that affect the HIV continuum of care. Establish patterns at the economic, demographic, and sociocultural factors that may fragment or, in a worst-case scenario, interrupt access to HIV testing, biomedical prevention, follow-up to a positive diagnosis, and adherence to treatment.
Resource (Conference Presentation) updated 09/14/2023
This presentation will provide an overview of the potential role of express STI services in HIV prevention and care and improving the clinic efficiency of RWHAP clinics and health centers by developing fast tracks for asymptomatic patients requiring STI testing.
Resource (Conference Presentation) updated 09/14/2023
Prism Health North Texas will share the challenges and successes of adapting Ryan White case management tools and strategies to a pre-exposure prophylaxis (PrEP) program for behavioral intervention. Panelists will detail how they took lessons learned from case management to HIV prevention to become status neutral.
Resource (Conference Presentation) updated 09/14/2023
In 2019, the Louisiana AIDS Drug Assistance Program (ADAP) partnered with a leading private dental insurer to design a group dental plan modeled after an employer-sponsored plan, specifically tailored to the needs of people with HIV. Both utilization and client satisfaction rose significantly following the adoption of the plan.
Resource (Conference Presentation) updated 09/14/2023
This discussion session will provide an overview of identified gaps and use of rebate funds can provide new access points for HIV medical care added through non-federal Ryan White Part B rebates to ensure access to Ryan White Part B services in areas with identified gaps in services.
Resource (Conference Presentation) updated 09/14/2023
This presentation will discuss the rapid antiretroviral treatment (ART) programs implemented at the University Health System in the San Antonio metropolitan area and the Baltimore City Health Department clinics, as well as preliminary results post-implementation, lessons learned, and plans for future quality improvement in both programs.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023